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AbstrAct
Neglected tropical diseases (NTDs) affect the poorest of 
the poor. NTD programmes can and should rise to the 
challenge of playing a part in promoting more gender 
equitable societies. Gender equity shapes poverty and 
the experience of disease in multiple ways; yet to date, 
there has been little attention paid to gender equity in 
NTD control efforts. Drawing on a synthesis of relevant 
literature, the tacit knowledge and experience of the 
authors, and discussions at a meeting on women, girls and 
NTDs, this analysis paper distills five key lessons from over 
20 years of gender mainstreaming in health. The paper 
links this learning to NTDs and Mass Drug Administration 
(MDA). Our first lesson is that tailored gender frameworks 
support gender analysis within research and programming. 
We present a gender review framework focusing on 
different MDA strategies. Second, gender interplays 
with other axes of inequality, such as disability and 
geographical location; hence, intersectionality is important 
for inclusive and responsive NTD programmes. Third, 
gender, power and positionality shape who is chosen as 
community drug distributors (CDDs). How CDDs interact 
with communities and how this interface role is valued 
and practised needs to be better understood. Fourth, 
we need to unpack the gender and power dynamics at 
household level to assess how this impacts MDA coverage 
and interactions with CDDs. Finally, we need to collect and 
use sex disaggregated data to support the development of 
more equitable and sustainable NTD programmes.
IntroductIon
Neglected tropical diseases (NTDs) are 
defined by the CDC as ‘a group of parasitic 
and bacterial diseases that cause substan-
tial illness for more than one billion people 
globally’.1 They affect some of the poorest 
and most marginalised people in the world.2 
Those affected by NTDs can face life-altering 
morbidity, which may result in disability, and 
have wide-ranging economic and social conse-
quences for individuals as well as their fami-
lies.3 Poverty, poor access to safe water and 
limited access to health services also enhance 
vulnerability to NTDs.3 These key structural 
barriers mean that communities and families 
living with NTDs, such as onchocerciasis and 
lymphatic filariasis, can remain trapped in a 
cycle of poverty.4 
NTD programmes have been relatively 
successful at promoting equity by ensuring 
that preventive approaches and treatments 
are accessible through Mass Drug Adminis-
tration (MDA) campaigns.5 MDA campaigns 
aim to ensure that all those living in affected 
communities have access to preventive 
chemotherapy through repeated school 
or community drug distribution. In very 
marginalised contexts, NTD programmes 
may be the only health services accessible to 
communities. For example, in 2015 during 
the Ebola outbreak, the NTD programme 
continued to function in some areas due to 
community persistence and the availability 
of drugs when many health services stopped 
(Karsor Kollie, Head of the Liberian NTD 
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Key questions
What is already known about this topic?
 ► Neglected tropical disease (NTD) programmes have 
paid little attention to gender analysis.
 ► Frameworks to promote and implement gender 
mainstreaming exist but have not been applied to 
NTDs.
What are the new findings?
 ► This paper draws together gender-related 
lessons learnt in the past 20 years from gender 
mainstreaming approaches in health and applies 
them to NTDs.
recommendations for policy
 ► We suggest practical, constructive approaches to 
support the development of more gender equitable 
NTD control programmes.
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programme; Personal Communication; 2016). In 
Yemen, despite ongoing conflict, treatments for NTDs 
are reaching vulnerable groups .6 WHO has described 
NTDs as the ‘litmus test for universal health coverage’ 
because they often affect the poorest and most margin-
alised who have poor access to healthcare.7 NTDs have 
also been included as an ‘equity’ tracer within the 
Sustainable Development Goals.8
Gender is a core concept in discussion and action 
related to equity. Gender refers to the socially 
constructed roles, behaviours, activities and attributes 
that a given society considers appropriate for men, 
women and other genders. These socially ascribed roles 
and behaviours can affect all aspects of peoples’ lives 
including their health and well-being.9 10 Gender roles 
and relations can shape peoples’ vulnerability to and 
experience of NTDs, how they experience poverty, and 
their ability to access care and treatment.11 Further-
more, gender can intersect with other axes of inequality 
such as age, nationality, ethnicity, religion, sexuality, 
(dis)ability and socioeconomic status.12 Who is involved 
in the delivery of NTD programmes at the community 
level and beyond, shapes how programmes are delivered 
and this is also influenced by gender.13 The NTD sector 
is working to strengthen the gender analysis that under-
pins its policy, programmes and data collection. This 
was the focus of a recent meeting (Neglected Tropical 
Diseases: Women and Girls in Focus, July, 2016)i that 
brought together donors, researchers, policy makers 
and practitioners from different contexts.14
The global health community has over 20 years’ expe-
rience of gender mainstreaming, a concept formalised 
at the Beijing International Women’s conference in 
1995.15 16 This analysis piece draws on a synthesis of 
relevant literature, tacit knowledge and experience 
of the authors, and discussions at the Women and 
Girls in Focus meeting. We reflect on five key lessons 
learnt from the gender mainstreaming process and 
their implications for donors, policy makers and prac-
titioners working in the NTD field, and highlight 
relevant lessons for promoting gender equity in NTD 
programmes. We explore this through the specific case 
study of MDA which has been a core prevention and 
treatment strategy for NTDs for several decades. We 
do however recognise the importance of considering 
gender equity in relation to other NTD interventions, 
such as innovative and intensified disease management, 
and disease management and disability and inclusion 
strategies in order to mainstream gender fully in NTD 
policy and programming.
i “Neglected Tropical Diseases: Women and Girls in Focus”; meeting 
held in London July 27-28. 2016 Organising committee: Camilla 
Ducker, DFID; Noelle Huskins, BMGF; Julie Jacobson, BMGF; Pamela 
Mbabazi, WHO; Amy Pennington, BMGF; Thoko Pooley, Uniting to 
Combat NTDs; Sarah Simpson, EquiACT.
Lesson 1: tailored gender frameworks help make the focus 
on gender explicit
Gender frameworks can help researchers, policy 
makers and practitioners understand and address the 
gender power relations which are most relevant to their 
work. Morgan et al10 identified 42 gender frameworks, 
guidelines and tools developed by a variety of agencies 
and organisations (15 of which focus on health, health 
systems and development).10 The health examples 
included a manual for integrating gender in reproduc-
tive health and HIV programmes and a guide by Pan 
American Health Organization (PAHO) to organise 
analysis and monitoring of gender equity in health poli-
cies.10 To date, no gender mainstreaming frameworks 
relate specifically to NTDs, which is a missed opportu-
nity for action.
To promote gender equity within MDA, we need to 
start by breaking down the different components of the 
intervention. MDA can be implemented in different ways 
depending on the context, target groups and diseases 
which are being treated and prevented. In table 1, 
drawing on discussions at the Women and Girls in Focus 
meeting, we have broken down the different elements of 
MDA, summarised the extent to which sex disaggregated 
data are collected and posed questions to support crit-
ical reflection on how gender may shape access to, and 
experiences of, MDA. This is not an exhaustive list, and 
the issues and questions under discussion may not be 
appropriate for all settings. Gender frameworks, such as 
in table 1, are most effective when used as a starting point 
for collective thinking to develop deeper understanding 
and ownership of gender issues and to ensure that the 
questions under review are appropriately adapted to 
context.17
Lesson 2: Gender does not operate in isolation: taking on the 
challenge of intersectionality
Gender interplays with other axes of privilege, power 
and inequity such as age, nationality, ethnicity, religion, 
sexuality, (dis)ability and socioeconomic status.18 Larson 
et al12 argue that ‘Intersectionality has emerged as an 
important framework for understanding and responding 
to health inequities by making visible the fluid and inter-
connected structures of power that create them’.12 Inter-
sectional analysis therefore allows for a more thorough 
and nuanced approach to promoting gender equity. 
Some of the gender questions above speak to how gender 
interplays with other axes of power and privilege, but it 
is important to recognise that individual positionalities 
are often shifting, and in the case of NTDs, very different 
positionalities may result in the same outcome—lack 
of access to MDA. Women with caring responsibilities 
within the home may encounter challenges in making 
time to come to a central location. Similarly, migrant or 
nomadic women or men may face particular challenges 
in accessing MDA, as might those living in fast growing 
urban informal settlements where MDA programmes 
have faced more challenges.19
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Table 1 Approaches to Mass Drug Administration (MDA) and why gender matters
Approach to MDA Data sex disaggregated
Questions for programme managers to consider from a 
gender perspective
House to house
Community drug 
distributors (CDDs)/
others visit households 
to register the household 
members and distribute 
drugs
Routinely reported data may 
be sex disaggregated at 
community level but frequently 
not cascaded to national level
 ► Who is chosen to distribute the drugs and why?
 ► How are they chosen and who is involved?
 ► Are they remunerated?
 ► Does this influence who is involved?
 ► At what time are drugs distributed?
 ► If it is in the evening is it acceptable/does it prompt security 
concerns?
 ► If daytime does this affect the involvement of those who have 
activities outside the home?
 ► Who is available within the household and when?
 ► Does CDD gender effect ability to access to household 
members or enter the home?
 ► Does this access also influence individual, household and 
community adherence?
 ► Who has the power to decide whether the medicines are 
taken or not?
 ► Who has the power to provide consent for household 
members under the age of 18 years?
 ► Do power relations at the community level also shape this?
Fixed point approaches: 
health post clinic/
distribution point
Drugs are distributed by 
CDDs or health workers at a 
fixed point
Routinely reported data may 
be sex disaggregated at 
facility level but frequently not 
cascaded to national level
 ► How and to whom is information communicated about the 
distribution—how does this reflect the needs of migrants, 
inhabitants of informal settlements, women, men, people of 
other genders?
 ► How does it reflect the literacy levels?
 ► Who is able to attend the distribution? How do livelihoods, 
gender, power and autonomy affect this?
 ► Does the location of distribution points influence distribution 
of medicines, what is the on impact community coverage or 
the coverage of any specific group within the community?
Child (under 5) health/
special events
Particularly common in 
the African context, drugs 
are provided within these 
gatherings
Routinely reported data not 
disaggregated at national level, 
with the possible exception of 
nutrition
 ► How and to whom is information communicated about the 
distribution—to what extent does this reflect the needs of 
women, men, people of other genders migrants, inhabitants 
of informal settlements?
 ► Who is able to attend the distribution? How does livelihoods, 
gender, power and autonomy affect this?
 ► Who has the power to provide consent for the treatment of 
those under 18 years of age?
School-based programmes
Teachers and/or others 
distribute drugs in the 
schools
Routinely reported data may 
be sex disaggregated at 
school level but frequently not 
cascaded to national level
 ► Who attends school?
 ► How is this linked to gender and poverty?
 ► How is informed consent negotiated?
 ► What happens to those who do not attend school on a 
regular basis?
 ► What happens to those who drop-out of school/do not 
complete their primary education?
Coverage improvement 
activities
for example, mop up
Additional ‘pro-equity’ 
activities undertaken to 
try to ensure everyone is 
covered
No sex disaggregated 
information and limited 
documentation on types of 
approaches
 ► What are the ‘coverage improvement’ strategies?
 ► Who decides on them?
 ► What baseline/census material do they relate to and who 
might be potentially excluded from these?
 ► Where appropriate how can we ensure women who are 
pregnant (and unable to take certain drugs) do access them 
at a later more appropriate date?
For example, in the Nubian Desert area of Sudan, Charles 
Mackenzie from Liverpool School of Tropical Medicine 
described how during the distribution of ivermectin, 
certain nomadic groups do not allow contact between 
nomad women and girls, and Sudanese health workers 
distributing the drugs; this presents difficulties in 
monitoring and provision of MDA to these individuals due 
to cultural and traditional norms.
Affected individuals can also be hidden within 
communities due to stigma and lack of perceived 
need.
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For example, in Nigeria people living with disability may 
be excluded from community level interventions such 
as house-to-house distribution due to confusion among 
CDDs regarding how to treat people living with disabilities, 
particularly when people are unable to stand or perceived 
to be sick due to their disability.20
In addition, disabled people may find the accessibility 
of fixed distribution points challenging. The involvement 
of disabled people as CDDs, as a mechanism to increase 
the involvement and integration of disabled people in 
community-based interventions, is rarely considered. 
These examples demonstrate how gender can interact 
with poverty, (dis)ability, occupation, power, geog-
raphy and other individual positionalities. We need to 
think about, and address, multiple interactions if MDA 
programmes are to be able to rise to the challenge of 
addressing and promoting equity. Other developments 
in gender mainstreaming include a critique of the male/
female binary and how this might limit analysis and 
action to address the needs of people of other genders. 
Using an intersectional lens to adapt existing gender 
frameworks to use for NTD programming would allow 
for a more structured approach to intersectional analysis.
Lesson 3: Gender power and participation—who gets chosen 
as community representatives and why it matters
There are many people involved in MDA campaigns and 
this often varies by disease programme.21 CDDs are argu-
ably the backbone of NTD programmes at the commu-
nity level and include teachers, midwives, nurses and 
lay people. The rationale behind CDDs is that they are 
selected by communities through a participatory process, 
and are trustworthy individuals who are committed to 
promoting community health. We have become accus-
tomed to the idea that community ownership is an 
essential element of NTD control, but communities are 
dynamic with complex power structures that may need 
better understanding and research in real time.22 Lessons 
from research on community health workers (CHWs) 
in five African contexts (that may be of relevance and 
provide lesson learning for the NTD community) show 
how respondents described several problems related to 
CHW selection. These included nepotism in the selec-
tion process; that the participants willing to undertake 
the role may not meet selection criteria (eg, older women 
and men may not meet the educational criteria); the diffi-
culty in recruiting young literate CHWs; early drop out 
due to misinformation about the job; and too few people 
volunteering.23 The ways in which selection of CDDs is 
carried out and the extent to which this mirrors or chal-
lenges gender norms within NTD programmes is not 
clear, but arguably the more open and participatory the 
process, the more chance the process could be gender 
equitable. Thus, although community participation strat-
egies may look equitable on paper, their implementation 
is often challenging and can have the unintended conse-
quence of reinforcing gender and social hierarchies 
within communities.
There are evidence gaps in understanding who CDDs 
are, by gender and by age. What is clear from the broader 
literature on CHWs is that gender matters. Naimoli et al24 
state that in many countries, women figure prominently 
as CHWs although this varies by context and by policy. 
In Ethiopia, all health extension workers are women and 
this was found to be positively valued by the community 
because of the perceived cultural suitability of women 
handling reproductive health issues.24 25 Raven et al’s7 23 
analysis from exploratory case studies using document 
reviews, in-depth interviews and focus group discussions 
shows that in the Democratic Republic of Congo, Senegal, 
Uganda and Zimbabwe, CHWs were reportedly more 
likely to be female and aged over 30 years. Older women 
were seen as being more interested in health issues; 
already involved in health within families; respected and 
listened to within communities; and perceived as being 
able to work easily with people. However, in Ghana, 
CHWs were more likely to be male as women are more 
occupied with taking care of their farms, homes and 
families.23 There is need to think critically about who 
is chosen to be a CDD, what this means for interactions 
within the community and how they are best supported 
to deliver on their important role.
Lesson 4: We need to unpack gender and power dynamics at 
household level
Gender analysts have long argued that we need to unpack 
the household and understand the ways in which gender, 
generation and power play out to affect who can make 
choices (including to seek healthcare), access resources 
and take medicines.26 27 CHWs (such as CDDs) often 
have to negotiate complex gendered decision-making 
processes when they visit house to house to deliver MDA.
An example provided at the meeting showed how in 
Mafia Island in Tanzania, fishermen go to their farms 
on the mainland (Rufiji) for several months at time, and 
leave their wives behind with the remaining family feeling 
unauthorised to make decisions about whether household 
members were ‘allowed to take drugs’. For pregnant 
women, gendered dynamics were also compounded by fear 
and lack of certainty as to whether it was safe to take drugs 
during pregnancy. The pressure to need to ‘be pregnant’ 
can give women a negative opinion of a drug that cannot 
be taken during pregnancy.
CDDs are well placed to understand these gendered 
dynamics as they are embedded and come from the 
communities they serve.28 As such, they could potentially 
address the social and cultural norms which can determine 
health outcomes by acting as agents for social change.28 
As CDDs may experience the same gender norms and 
power dynamics as other members of their community, it 
is important to enhance their critical awareness of these 
factors and how they have an impact on health. This 
requires ongoing supportive supervision structures and 
strategies to enable CDDs to reflect on how they promote 
gender equity in their work, which ‘coverage improve-
ment’ strategies will be most appropriate in different 
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contexts, including on particularly neglected NTDs such 
as female genital schistosomiasis.29
Parker and Allen’s30 work on MDA programmes has 
highlighted the importance of consent and community 
engagement and how at times community members 
may feel consent is lacking.30 CDDs are a critical bridge 
between the community and health programmes.31 They 
have underused tacit knowledge about the challenges, 
opportunities and concerns of different community 
members with respect to MDA, and how these are shaped 
by gender and other axes of marginality. Creating forums 
through which CDDs can share their experiences has 
the potential to strengthen the responsiveness of NTD 
programmes and ensure that programmes are adaptable 
to the realities that community members face. Greater 
involvement in advising health programmes can also lead 
to the greater recognition of CDDs and support career 
advancement and progression, which is particularly 
important for often underpaid and under-recognised 
women providers. Furthermore, as the majority of CDDs 
are unpaid, giving them an opportunity to better under-
stand and feed into MDA processes may increase their 
motivation and sense of job satisfaction.
Lesson 5: We need to bring a critical gender lens to data at all 
times
Lessons from gender mainstreaming include the need to 
think critically about data, how it is collected, its quality 
and what it represents. Collecting and using sex disag-
gregated data to improve the gender equity and respon-
siveness of NTD programmes, especially at district and 
community levels, is important. The WHO introduced 
sex disaggregated reporting forms in 2009. However, 
how this disaggregated data is reported, collected and 
used is not always clear. Disaggregated data are rarely 
found at the national or global level. It is possible that 
some of the data collected is sex disaggregated at the 
community level, but this disaggregation is then lost at 
national level, meaning that important patterns in terms 
of gender, age and geography are disguised and cannot 
be acted on. Additionally, collation and aggregation of 
sex disaggregated at higher levels of the health system 
may mask gender inequity which is prevalent at local 
levels, and at specific to certain communities. Partici-
pants at the meeting committed to disaggregating by sex 
and age as the minimum requirement for programmes. 
However, this commitment could go further by adding 
questions to coverage evaluation surveys and data quality 
assessments to provide insights into gender equity. Qual-
itative and participatory research can also support with 
better understanding of how gender influences expe-
riences, access to MDA and strategies to document the 
tacit knowledge of CDDs.
Tanya Wood from the International Federation of Anti-
Leprosy Associations raised an important concern relating 
to how data are collected. She provided an example of how 
leprosy data have been disaggregated demonstrating that 
in some contexts, more men have leprosy than women and 
that this has been taken at face value in the figures that 
are reported by WHO and others. She explained that in 
reality, women were not showing up in the data because 
of the multiple challenges they face in accessing care and 
treatment.
While collecting and disaggregating data is important, 
the ways these data are collected can make certain groups 
invisible and this is especially problematic when data are 
collected at health centres rather than within households 
at the community level.
concLusIon
In this paper, we have outlined learning from the expe-
riences of 20 years of gender mainstreaming and linked 
this learning to the MDA activities commonly used as a 
strategy in the control and elimination of NTDs. We have 
made the argument that gender matters and needs to be 
more effectively addressed by the NTD community and 
more actively incorporated into the development and 
implementation of NTD programmes. The success of 
elimination relies on programmes that reach the endemic 
population and thus effectively break transmission. A ‘stra-
tegic framing’16 that could be used to argue for greater 
gender analysis is that it makes programmes more equi-
table, but by reducing infection and supporting CDDs, 
NTD programmes will become efficient and sustainable. 
The inclusion of gender-informed analysis and action is 
a win–win situation as it helps to ensure support to and 
engagement with communities, affected individuals and 
CDDs. It is important to acknowledge that providing this 
form of support may increase costs in the short term, 
but ultimately it could lead to more effective allocation 
of resources to those most affected. Researchers should 
develop pathfinding studies to generate more evidence 
to inform policy frameworks and related guidelines for 
gender mainstreaming within national NTD programmes. 
Ultimately, we need to ensure that our approaches do no 
harm, leave no one behind,6 do not exacerbate pre-ex-
isting inequalities, and are carried out in an ethically and 
culturally aware manner. NTD programmes should also 
rise to the challenge promoting more gender equitable 
societies. Through the strengthening of the systems that 
have been developed over the past 30 years to distribute 
NTD drugs to those living at the ‘end of the road’, these 
programmes can be a powerful mechanism for making 
strides towards achieving universal healthcare: an oppor-
tunity that must not be lost.
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